Message #9 From:
NewsBot Date: October 23, 2006 04:50:00 AM
AIS News Antares Pharma to Present at Rodman & Renshaw 8th Annual Healthcare Conference
EWING, N.J.--(BUSINESS WIRE)--Antares Pharma, Inc. (Amex:AIS)
announced that Jack E. Stover, President & Chief Executive Officer is
scheduled to present at the Rodman & Renshaw Annual Healthcare
Conference on Monday, November 6, 2006 at 11:20 am (ET) at the Palace
Hotel in New York City. A live webcast of the audio portion of this
presentation will be available via http://www.wsw.com/webcast/rrshq10/ais
and will be archived for 90 days.
Antares Pharma is a specialized pharma product development company
focused on developing patented drug delivery systems and injectable
device engineering capabilities. Antares’
current technology platforms include its ATD™
Advanced Transdermal Delivery system, and its related TecTix™
system for topical and transmucosal delivery, its Easy Tec™
oral fast-melt technology, and subcutaneous injection technology
platforms including both Vibex™ disposable
mini-needle injection device and Valeo™/Vision®
reusable needle-free injection devices. Antares Pharma is committed to
leveraging its multiple drug delivery platforms to add value to existing
drugs and to create new pharmaceutical products and injectable devices.
Overall, Antares’ product pipeline, if
approved, will address unmet medical needs by reducing side effect
profiles, improving safety, increasing effectiveness, and improving
patient compliance and convenience. Antares Pharma has corporate
headquarters in Princeton Crossroads Corporate Center in Ewing, NJ, with
subsidiaries performing research, development, manufacturing and product
commercialization activities in Minneapolis, Minnesota and Basel,
Switzerland.
